Alpha Cubed Cuts CME Group Stake by 2.6%, Sells 2,416 Shares

CMECME

Alpha Cubed Investments LLC cut its CME Group stake by 2.6%, offloading 2,416 shares, leaving it with 91,667 shares valued at $24.77 million. The stake now comprises 0.9% of the firm's portfolio, ranking as its 28th largest position.

1. Institutional Ownership Shifts

During the third quarter, Alpha Cubed Investments LLC trimmed its position in CME Group by 2.6%, disposing of 2,416 contracts and ending the period with 91,667 contracts valued at $24.8 million. Meanwhile, Norges Bank initiated a substantial new stake worth $1.57 billion, marking one of the largest foreign sovereign positions in the exchange operator. Viking Global Investors also entered the stock with a $165 million commitment, and Vanguard Group increased its holding by 1.5%, accumulating an additional 532,549 contracts to reach a total position valued at $9.7 billion. Magellan Asset Management boosted its exposure by over 480,000 contracts—an increase of more than 130,000%—resulting in a $134 million position. In total, institutional investors now own 87.8% of CME Group shares outstanding.

2. Analyst Ratings and Target Adjustments

Over the past three months, nine brokerages have maintained a positive outlook on CME Group, issuing buy or overweight recommendations, while six have held neutral stances and three have advocated selling. Argus reduced its twelve-month target from $308 to $295, citing near-term volume headwinds. Deutsche Bank raised its forecast to $318 on expectations of resilient open interest growth in interest rate derivatives. Piper Sandler lifted its objective from $296 to $313, highlighting sustained demand for cleared products. Royal Bank of Canada adjusted its target upward to $295, pointing to margin expansion in clearing services, whereas Goldman Sachs cut its estimate from $265 to $264 based on anticipated pressure from lower transaction fees.

3. Key Financial Metrics and Dividend Policy

CME Group reported a market capitalization in excess of $100 billion and trades with a trailing price-earnings multiple near 28x, reflecting a premium to its five-year average amid steady fee revenue. The company’s twelve-month share price range spans from $233 to $292, and its beta of 0.27 underscores defensive characteristics relative to equity markets. On December 30, the exchange paid a quarterly dividend of $1.25 per share, equating to a 1.7% annualized yield and a payout ratio of approximately 48%. At quarter end, available liquidity and a conservative debt-to-equity ratio of 0.12 reaffirmed the firm’s strong balance sheet heading into 2026.

Sources

DBZ